Sparta Systems, Inc., is an enterprise software development company that has developed configurable solutions for logging, tracking, and trending of quality assurance and GxP issues. Over the past six years Sparta, utilizing its own cutting edge technology, has positioned itself as the leader in providing configurable quality management systems for FDA regulated industries.
Sparta's mission is to provide state-of-the-art enterprise-wide software management tools that streamline operations, lower costs and improve quality. The company's flagship product, TrackWise®, was developed with the vision that all business organizations will benefit from using a versatile, powerful, and off the shelf tracking tool that is highly user-configurable.
TrackWise has been successfully implemented as a 21 CFR Part 11 compliant solution in over 75 life sciences companies for management of cGxP compliance, including: Nonconformance, Deviations/Incidents, Investigations, Customer Complaints, Audit Management, Corrective and Preventive Actions (CAPA), Change Authorizations, and more. Some of SSI's larger customers include: Merck & Co., Schering-Plough, Pfizer, Wyeth, Hoffmann-La Roche Pharmaceutical, Roche Diagnostics, Amgen, Genentech, Biogen, Aventis, Solvay Pharmaceuticals, GlaxoSmithKline, and Bayer.
As the customer base has grown, the company has stayed current with business needs, introducing additional products to the TrackWise suite, including the TrackWise Coordinator®, TrackWise Offline?, TrackWise Audit Manager?, and numerous integration tools. Sparta has applied for patents on its innovative technology and features. Today, TrackWise has taken its place as the enterprise quality management system (QMS) in the portfolio of many of its customers.
Along with maintaining technological leadership, SSI has established an experienced professional services group that has implemented TrackWise throughout its customer base. Providing services ranging from pre-sale consulting, to implementation, validation assistance, and training, SSI offers the most professional services available to ensure efficient deployment, and ongoing, dedicated support to maintain customer satisfaction.
SSI currently is growing rapidly, continuously recruiting additional staff members and expanding R&D, Sales and Customer Support. Led by Ran J. Flam, founder, President & CEO, the company has exceeded expectations, doubling its sales in each of the past 6 years, while maintaining profitable operation since 1995.
Today, the company is focusing on developing additional complimentary solutions, and expanding its presence in the FDA regulated, and other regulated markets. It has been establishing regional offices, and developing partnerships with other firms that serve the industry. Recently the company received a $14 million investment from AIG Healthcare Partners, L.P. – less – More from ZoomInfo »